1. Home
  2. CENT vs STOK Comparison

CENT vs STOK Comparison

Compare CENT & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Central Garden & Pet Company

CENT

Central Garden & Pet Company

HOLD

Current Price

$33.03

Market Cap

2.1B

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$30.68

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENT
STOK
Founded
1955
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CENT
STOK
Price
$33.03
$30.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$50.00
$34.50
AVG Volume (30 Days)
66.8K
813.5K
Earning Date
02-04-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
57.41
N/A
EPS
2.55
0.68
Revenue
$3,129,064,000.00
$205,632,000.00
Revenue This Year
$2.17
$430.24
Revenue Next Year
$2.13
N/A
P/E Ratio
$12.98
$44.66
Revenue Growth
N/A
1128.17
52 Week Low
$28.77
$5.35
52 Week High
$41.25
$38.69

Technical Indicators

Market Signals
Indicator
CENT
STOK
Relative Strength Index (RSI) 56.11 45.86
Support Level $31.41 $25.21
Resistance Level $32.57 $37.34
Average True Range (ATR) 0.60 1.89
MACD 0.05 -0.41
Stochastic Oscillator 84.85 44.52

Price Performance

Historical Comparison
CENT
STOK

About CENT Central Garden & Pet Company

Central Garden & Pet Co offers solutions that support healthier pets, greener lawns, and thriving gardens. Its products include dog and cat treats, chews, toys, beds, containment, grooming supplies, aquatics, small animal and bird supplies, equine and livestock products, insect control solutions, grass seed, wild bird feed, fertilizers, pest controls, live plants, and packet seeds, sold under brands such as Aqueon, Nylabone, Kaytee, Farnam, Pennington, Ferry Morse, Amdro, and Sevin. The company operates through two segments, Pet and Garden, and sells through retailers, independent stores, eCommerce channels, and professional markets. It has sales and distribution operations mainly across the United States, with additional facilities in Canada and Mexico.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: